Introduction
Leishmaniasis is a parasitic infection caused by protozoa of the genus Leishmania and spread by the bite of infected female sandflies. It ranges from skin sores to severe systemic illness that can threaten life if untreated.
The main clinical forms are cutaneous leishmaniasis (skin ulcers), mucocutaneous leishmaniasis (nose, mouth, and throat tissues), and visceral leishmaniasis—also called kala-azar—which involves the liver, spleen, bone marrow, and other organs.
It is most common in tropical and subtropical regions of South America, Africa, the Middle East, and Asia. Risk rises with outdoor exposure in endemic areas, sandfly-friendly environments, and weakened immunity, including advanced HIV.
This page summarises causes, symptoms, diagnosis, treatment, prevention, complications, and when to seek care. It is general education—not a personal diagnosis. Suspected infection needs clinician evaluation, especially after travel to endemic areas.
Overview
Leishmaniasis is vector-borne: parasites enter when an infected sandfly takes a blood meal. Species of Leishmania and the host immune response largely determine whether disease stays in the skin or becomes visceral.
Cutaneous disease may heal slowly but can scar. Mucocutaneous disease can disfigure facial structures. Visceral disease causes prolonged fever, weight loss, anaemia, and enlarged spleen or liver and can be fatal without prompt therapy.
Management depends on form and severity—from observation or topical care for limited skin lesions to systemic antiparasitic drugs and supportive care for mucocutaneous or visceral disease.
- Caused by Leishmania parasites transmitted by sandfly bites
- Three main forms: cutaneous, mucocutaneous, and visceral (kala-azar)
- Endemic in parts of South America, Africa, the Middle East, and Asia
- Not spread person-to-person through casual contact
- Diagnosis uses history, exam, labs, imaging, and sometimes biopsy or bone-marrow sampling
- Treatment is form-specific: topical, systemic antimonials, amphotericin B, or miltefosine as indicated
- Bite prevention and environmental control reduce risk; no licensed vaccine is widely available yet
What happens in the body
After a sandfly bite, parasites infect immune cells (especially macrophages) and multiply. In cutaneous disease they stay mainly in the skin; in visceral disease they seed internal organs and suppress normal blood-cell production.
Climate, humidity, stagnant water, urbanisation, and deforestation influence sandfly habitats. Malnutrition and immunodeficiency impair clearance of infection and raise the chance of severe disease.
- Sandfly bite introduces Leishmania into the host
- Parasites survive inside macrophages and spread locally or systemically
- Immune status and parasite species shape clinical form
- Warm, humid, endemic settings favour transmission
- HIV and other immunocompromise worsen visceral outcomes
Signs and symptoms
Symptoms depend on the form of leishmaniasis. You may not have every feature:
- Cutaneous: skin sores or ulcers weeks to months after a bite—painless or painful
- Cutaneous: lesions that heal slowly and may leave scars
- Mucocutaneous: nasal congestion, nosebleeds, mouth or throat lesions
- Mucocutaneous: progressive damage to nose or oral tissues if untreated
- Visceral: prolonged or recurrent fever
- Visceral: unintended weight loss and marked fatigue
- Visceral: anaemia and other blood-count abnormalities
- Visceral: enlarged spleen and/or liver with abdominal fullness or swelling
- Secondary infection of open skin lesions
- Difficulty breathing or swallowing when mucosal disease advances
Causes and risk factors
Infection follows parasite exposure; several factors raise risk:
- Bite of an infected female sandfly in an endemic area
- Living in or travelling to South America, Africa, the Middle East, or parts of Asia where transmission occurs
- Outdoor or rural work that increases sandfly exposure
- Environments with stagnant water, high humidity, and warm temperatures that support sandfly breeding
- Young children and older adults with weaker immune responses
- Male sex in some settings due to occupational outdoor exposure
- HIV/AIDS, diabetes, malnutrition, or other immunosuppression
- Genetic differences in immune response may influence severity (research ongoing)
- Not caused by casual person-to-person contact in everyday settings
Diagnosis and evaluation
Diagnosis combines exposure history with confirmatory tests—appearance alone is not enough:
- Clinical history: symptoms, sandfly exposure, and travel or residence in endemic regions
- Physical examination of skin, mucosa, abdomen (spleen/liver), and overall nutritional status
- Blood tests for antibodies or parasite detection where available
- Ultrasound or CT when visceral organ involvement is suspected
- Skin-lesion biopsy or bone-marrow aspiration to identify parasites in selected cases
- Differential diagnosis versus other parasitic, skin, or systemic illnesses that look similar
Treatment and management
Therapy is tailored to disease form and severity. Do not self-medicate with antiparasitic drugs:
- Limited cutaneous lesions: some heal without drugs; topical agents (for example paromomycin or imiquimod) may be used when appropriate
- More extensive cutaneous disease: systemic therapy such as pentavalent antimonials under specialist supervision
- Mucocutaneous disease: systemic pentavalent antimonials or amphotericin B
- Visceral leishmaniasis: liposomal amphotericin B, miltefosine, or other regimen per local guidelines—often with hospital monitoring
- Supportive care: nutrition, hydration, and treatment of secondary infections
- Dose adjustment and closer monitoring in children and older adults with comorbidities
- Balanced diet and wound hygiene to support healing; complementary therapies only after clinician discussion
- Complete the full prescribed course—incomplete therapy raises relapse and resistance risk
Prevention, self-care, and lifestyle
Not every condition is fully preventable, but the steps below may lower risk or recurrence:
- In endemic areas, use insect repellent and wear long sleeves and trousers, especially at dusk and night
- Sleep under insecticide-treated nets where sandflies are active
- Reduce standing water and improve sanitation around dwellings when feasible
- Travellers to endemic regions should seek pre-travel advice on bite avoidance
- No widely approved vaccine is currently available; research continues
- Good nutrition and HIV care reduce vulnerability to severe disease
Possible complications
Delay, missed care, or unsafe self-medication can raise the chance of complications in some cases:
- Cutaneous scarring and secondary bacterial infection of ulcers
- Mucocutaneous disfigurement and impaired nasal or oral function
- Visceral organ failure, life-threatening anaemia, and opportunistic infections
- Death from untreated or late-treated visceral leishmaniasis
- Long-term psychological and social impact from visible scarring or facial change
- Relapse, especially with incomplete treatment or immunosuppression
When to see a doctor or seek emergency care
Seek prompt medical advice or emergency care if any of the following apply—it is safer not to wait and see:
- Persistent fever or rapid unexplained weight loss after travel to or residence in an endemic area
- Severe abdominal pain or progressive abdominal swelling
- Difficulty breathing or swallowing
- Skin lesions that do not heal, worsen, or show spreading redness, pus, or fever
- Nosebleeds with progressive nasal blockage or mouth/throat sores after endemic exposure
- Known immunosuppression with any suggestive systemic symptoms—seek care promptly
Living with the condition
If treated for visceral or mucocutaneous disease, keep follow-up appointments and report fever or weight loss early. Rest and nutritious food support recovery.
Protect healing skin lesions from dirt and secondary infection; ask about scar care if cosmetic concerns persist.
When returning to endemic areas, renew bite-prevention habits. Share your diagnosis history with clinicians who may not know your travel background.
Frequently asked questions
What are the main symptoms of leishmaniasis?
They vary by form: skin sores in cutaneous disease; nasal or oral lesions in mucocutaneous disease; and fever, weight loss, anaemia, and enlarged spleen or liver in visceral disease.
How is leishmaniasis diagnosed?
Clinicians use exposure history, examination, blood tests, imaging when needed, and sometimes biopsy or bone-marrow sampling to confirm parasites.
Is leishmaniasis contagious between people?
Ordinary casual contact does not spread it. Transmission is primarily through infected sandfly bites, not typical person-to-person touch.
Can leishmaniasis be prevented?
Yes—bite avoidance (repellents, clothing, treated nets) and environmental measures help. A routine licensed vaccine is not yet widely available.
How long does treatment take?
Duration varies: limited skin disease may resolve over weeks; visceral disease often needs weeks to months of supervised therapy.
Who is at higher risk?
People living or working outdoors in endemic regions, young children, older adults, and those with weakened immunity face higher risk of infection or severe disease.
Important caution
This article is for general health education only. It is not personal medical advice or a substitute for laboratory diagnosis.
Fever, progressive weight loss, non-healing ulcers, or mucosal damage after endemic exposure need prompt clinical assessment.
Early recognition and form-appropriate treatment greatly improve outcomes for most people.